Importantly, IKE-treated TIPE2−/− tumor MDSCs pretreated with L-NAC further reduced their ability to block T cell proliferation, compared with those from IKE-treated WT controls (Figure 3g and Figure S3c). The gene discussed is TIPE2; the disease is neoplasm.